Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies is a research paper published in Molecular Therapy — Methods & Clinical Development (2020). On theSindex it has a DataRank of 0.477. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.477
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: R37 AI018289
NIAID NIH HHS
Grant: R01 AI018289
National Institutes of Health
Grant: 2R01AI018289-09
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINS
Alliance for Cancer Gene Therapy
National Institutes of Health
FWCI
2.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals